Instil Bio, Inc.TILNASDAQ

Revenue (LTM)

Net Income (LTM)

$-74M

+52.5% YoY

Free Cash Flow

$-66M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	-6	0	0
Operating Income	-34	-156↓362.4%	-206↓32.5%	-159↑22.8%	-74↑53.8%
Net Income	-38	-157↓315.5%	-223↓42.3%	-156↑30.1%	-74↑52.5%
EBITDA	-33	-153↓356.8%	-217↓42.5%	-147↑32.3%	-63↑57.5%
EPS Diluted	-5.89	-29.60↓402.5%	-34.46↓16.4%	-24.00↑30.4%	-11.39↑52.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	242	38↓84.4%	44↑16.3%	9↓79.0%	9↓4.2%
Total Current Assets	246	464↑88.5%	269↓41.9%	161↓40.3%	124↓22.6%
Total Assets	319	610↑91.2%	482↓21.0%	326↓32.5%	264↓19.1%
Total Current Liabilities	13	41↑211.4%	33↓20.7%	11↓67.8%	8↓25.2%
Total Liabilities	27	55↑105.6%	119↑116.3%	100↓15.8%	94↓5.7%
Total Equity	292	555↑89.9%	364↓34.5%	226↓37.9%	169↓25.0%
Total Debt	0	0	80	86↑7.7%	87↑1.0%
Net Debt	-242	-38↑84.4%	36↑196.3%	77↑112.4%	78↑1.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-30	-122↓312.4%	-180↓47.5%	-82↑54.5%	-56↑32.1%
Capital Expenditure	-51	-58↓13.8%	-85↓46.3%	-21↑75.6%	-10↑51.6%
Free Cash Flow	-80	-180↓123.8%	-265↓47.1%	-103↑61.2%	-66↑36.0%
Stock-Based Comp	2	26↑1435.6%	30↑16.2%	18↓40.3%	17↓5.0%
Net Change in Cash	233	-204↓187.5%	6↑102.8%	-33↓686.9%	-0↑99.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance